Lindsay A Parker, Brandan Wustefeld-Janssens, James M Dundas
{"title":"Transient Postoperative Hemorrhage from Elbow Arthroscopy Portals following Intra-Articular Pentosan Polysulfate Sodium Injection.","authors":"Lindsay A Parker, Brandan Wustefeld-Janssens, James M Dundas","doi":"10.1155/2022/9428539","DOIUrl":null,"url":null,"abstract":"<p><p>Four adult, client owned dogs with diagnosed bilateral elbow dysplasia undergoing elbow arthroscopy for removal of fragmented medial coronoid process were identified via a retrospective database search, who also received intra-articular administration of pentosan polysulfate sodium (PPS) (Cartrophen Vet, Biopharm Australia Pty Ltd., Bondi Junction, New South Wales). Dogs had postoperative administration of 5 ml PPS injected into each elbow joint following elbow arthroscopy. Within 1-3 hours of administration, each dog experienced hemorrhage from arthroscopy incisions that was determined to be independent of surgical trauma given lack of hemorrhage intraoperatively. Pressure bandages were placed, and the hemorrhage and elevated coagulation parameters resolved 12-18 hours following intra-articular injection. No further intervention was required, and the dogs were discharged 20-26 hours postoperatively. The purpose of this case series is to describe 4 dogs who experienced transient and focal hemorrhage following off-label intra-articular administration of pentosan polysulfate sodium (PPS). While this case series is limited due to small number of cases, results following bilateral, intra-articular injection of PPS support a transient systemic coagulopathy. Though this report represents administration of PSS via a route and at doses beyond that recommended on the label, results suggest that administration of PSS in the manner described in this report should be avoided.</p>","PeriodicalId":37339,"journal":{"name":"Case Reports in Veterinary Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536980/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Veterinary Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/9428539","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Veterinary","Score":null,"Total":0}
引用次数: 0
Abstract
Four adult, client owned dogs with diagnosed bilateral elbow dysplasia undergoing elbow arthroscopy for removal of fragmented medial coronoid process were identified via a retrospective database search, who also received intra-articular administration of pentosan polysulfate sodium (PPS) (Cartrophen Vet, Biopharm Australia Pty Ltd., Bondi Junction, New South Wales). Dogs had postoperative administration of 5 ml PPS injected into each elbow joint following elbow arthroscopy. Within 1-3 hours of administration, each dog experienced hemorrhage from arthroscopy incisions that was determined to be independent of surgical trauma given lack of hemorrhage intraoperatively. Pressure bandages were placed, and the hemorrhage and elevated coagulation parameters resolved 12-18 hours following intra-articular injection. No further intervention was required, and the dogs were discharged 20-26 hours postoperatively. The purpose of this case series is to describe 4 dogs who experienced transient and focal hemorrhage following off-label intra-articular administration of pentosan polysulfate sodium (PPS). While this case series is limited due to small number of cases, results following bilateral, intra-articular injection of PPS support a transient systemic coagulopathy. Though this report represents administration of PSS via a route and at doses beyond that recommended on the label, results suggest that administration of PSS in the manner described in this report should be avoided.
通过回顾性数据库搜索,确定了4只诊断为双侧肘关节发育不良的成年狗,它们正在接受肘关节镜检查,以去除碎片状的内侧冠突,同时也接受了关节内注射聚硫酸钠(PPS) (cartroen Vet, Biopharm Australia Pty Ltd, Bondi Junction, New South Wales)。术后犬在肘关节镜检查后每个肘关节注射5ml PPS。在给药1-3小时内,每只狗都出现了关节镜切口出血,由于术中没有出血,因此确定与手术创伤无关。施加压力绷带,关节内注射后12-18小时出血和凝血参数升高消失。无需进一步干预,术后20-26小时出院。本病例系列的目的是描述4只狗在未经核准的情况下关节内注射戊聚糖聚硫酸钠(PPS)后出现短暂性和局灶性出血。虽然该病例系列由于病例数量少而受到限制,但双侧关节内注射PPS后的结果支持一过性全身性凝血病。虽然本报告表明PSS的给药途径和剂量超出了标签上推荐的剂量,但结果表明,应避免以本报告中描述的方式给药PSS。
期刊介绍:
Case Reports in Veterinary Medicine is a peer-reviewed, Open Access journal that publishes case reports and case series in all areas of veterinary medicine.